Showing results (1441-1450 of 2,067) with videos related to

Sort By:
Pageof 207
Infection and Immunity|May 28, 2015
Host-like carbohydrates promote bloodstream survival of Vibrio vulnificus in vivoJean-Bernard Lubin, Warren G Lewis, Nicole M Gilbert, et al.
International Journal of Cancer|March 17, 2000
Prognostic significance of serum p53 antibodies in patients with limited-stage small cell lung cancerG Zalcman, J Trédaniel, B Schlichtholz, et al.
The Journal of Laboratory and Clinical Medicine|October 1, 1989
Qinghaosu-mediated oxidation in normal and abnormal erythrocytesM D Scott, S R Meshnick, R A Williams, et al.
Biochimica Et Biophysica Acta. Biomembranes|October 22, 2018
Studies of membranotropic and fusogenic activity of two putative HCV fusion peptidesSimon Gonzalez, Florian Gallier, Sabrina Kellouche, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 27, 2005
Expression of the pregnane X receptor in mice antagonizes the cholic acid-mediated changes in plasma lipoprotein profileDavid Masson, Laurent Lagrost, Anne Athias, et al.
Epidemiology (Cambridge, Mass.)|June 14, 2005
Organochlorines in carpet dust and non-Hodgkin lymphomaJoanne S Colt, Richard K Severson, Jay Lubin, et al.
Gut|March 1, 1997
Detection and monitoring of serum p53 antibodies in patients with colorectal cancerP Hammel, B Boissier, M T Chaumette, et al.
Frontiers in Medicine|August 30, 2018
Virulence Factors and Antibiotic Resistance of Klebsiella pneumoniae Strains Isolated From Neonates With SepsisKhalit S Khaertynov, Vladimir A Anokhin, Albert A Rizvanov, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 28, 2015
Association between Nondominant Unit Total Nucleated Cell Dose and Engraftment in Myeloablative Double-Unit Cord Blood TransplantationDuncan Purtill, Cladd E Stevens, Marissa Lubin, et al.
Annals of Internal Medicine|November 4, 2009
Treatment of very early rheumatoid arthritis with symptomatic therapy, disease-modifying antirheumatic drugs, or biologic agents: a cost-effectiveness analysisAxel Finckh, Nick Bansback, Carlo A Marra, et al.
Pageof 207